49 completed, 9 unknown, 8 recruiting, 8 terminated. 86 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 86 | Completed 49, Unknown 9, Recruiting 8, Terminated 8, Active not recruiting 4, Not yet recruiting 4, Suspended 2, Enrolling by invitation 1, Withdrawn 1 |
Follow Prostate Cancer: new trials by email Literature Review of Prostate Cancer trials Research Report on Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Darolutamide, Physician choice Androgen Deprivation (Hormone) Therapy - Prostate Cancer | Phase 4 | Not yet recruiting | University of Chicago | 80 | 2026-11-01 | 2026-01-08 |
| Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients. Experimental - Elderly, Breast Cancer | Phase 4 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 794 | 2026-09-01 | 2026-09-03 |
| Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance Testosterone cypionate - Prostate Cancer, Hypogonadism, Male | Phase 4 | Not yet recruiting | University of Miami | 35 | 2026-08-31 | 2026-07-22 |
| Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence fluciclovine (18F) - Prostate Cancer | Phase 4 | Recruiting | Blue Earth Diagnostics | 142 | 2026-08-31 | 2026-10-07 |
| Autonomic and Renal Contributions to Hypertension With ADT Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer | Phase 4 | Recruiting | Virginia Commonwealth University | 50 | 2026-08-01 | 2026-09-30 |
| 177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial Darolutamide combined with 177Lu-PSMA-617 - Prostate Cancer, Prostate Cancer Patients | Phase 4 | Not yet recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 20 | 2026-07-01 | 2026-07-01 |
| Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy Semaglutide Pen Injector - Prostate Cancer | Phase 4 | Active not recruiting | Hamilton Health Sciences Corporation | 20 | 2025-07-02 | 2026-09-14 |
| COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer Darolutamide Oral Tablet, leuprorelin - Prostate Cancer | Phase 4 | Active not recruiting | Brazilian Clinical Research Institute | 144 | 2025-02-17 | 2026-02-11 |
| Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy flotufolastat (18F), piflufolastat (18F) - Prostate Cancer | Phase 4 | Completed | Blue Earth Diagnostics | 62 | 2024-12-04 | 2026-07-13 |
| Prostate MRI and Pylarify PSMA PET/CT Pylarify Piflufolastat Flourine-18 (18F-DCFPyL) - Prostate Cancer | Phase 4 | Withdrawn | Corewell Health East | 2024-10-01 | 2025-01-03 | |
| Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study) Oxycodone oral capsule 15 mg, Abiraterone Acetate Tablets 500 mg - Prostate Cancer, Pain Cancer | Phase 4 | Recruiting | Deventer Ziekenhuis | 29 | 2024-04-12 | 2025-06-03 |
| Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan 18F-DCFPyl - Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 4 | Recruiting | Brigham and Women's Hospital | 30 | 2024-04-01 | 2026-01-29 |
| Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery fresh frozen plasma, prothrombin complex concentrate - Prostate Cancer, Spine, Open | Phase 4 | Unknown | Konkuk University Medical Center | 154 | 2024-03-01 | 2024-01-02 |
| Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain Early TAP Block, Late TAP Block - Prostate Cancer | Phase 4 | Enrolling by invitation | Corewell Health East | 94 | 2024-02-19 | 2026-04-23 |
| Gadopiclenol in Contrast Enhanced MRI of the Prostate Gadopiclenol - Prostate Cancer | Phase 4 | Suspended | Columbia University | 150 | 2024-02-14 | 2026-07-20 |
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery TXA, TEG6 - Arthritis Knee, Spine Fusion | Phase 4 | Unknown | Konkuk University Medical Center | 148 | 2024-02-10 | 2024-05-14 |
| PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer Piflufolastat F 18 Intravenous Solution [PYLARIFY] - Prostate Cancer | Phase 4 | Active not recruiting | Lantheus Medical Imaging | 274 | 2024-02-08 | 2025-09-11 |
| Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks ICG injection, Non-Injection/Control, Prostatectomy with pelvic lymph node dissection - Lymphocele, Prostate Cancer | Phase 4 | Unknown | Kaiser Permanente | 100 | 2024-02-01 | 2024-02-26 |
| Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort lidocaine and sufentanil, Saline - Prostate Cancer | Phase 4 | Unknown | RenJi Hospital | 140 | 2023-10-07 | 2023-07-24 |
| Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET Fluciclovine PET/CT - Prostate Cancer | Phase 4 | Active not recruiting | OHSU Knight Cancer Institute | 50 | 2023-10-04 | 2026-06-29 |
Showing 20 of 86. Sign in to see all of them.
Prostatic Neoplasms (86) · Neoplasms (5) · Breast Neoplasms (4) · Kidney Diseases (3) · Kidney Neoplasms (3) · Prostatic Hyperplasia (3) · Anxiety Disorders (2) · Hypertension (2) · Neoplasm Metastasis (2) · Pain (2) · Primary Dysautonomias (2) · Acromegaly (1) · Bone Diseases, Metabolic (1) · Cancer Pain (1) · Cholecystitis (1)
Genital Diseases (86) · Genital Diseases, Male (86) · Genital Neoplasms, Male (86) · Male Urogenital Diseases (86) · Neoplasms by Site (86) · Urogenital Neoplasms (86) · Prostatic Diseases (85) · Urogenital Diseases (85) · Neoplasms (81) · Pathological Conditions, Signs and Symptoms (11) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Urologic Diseases (7) · Cardiovascular Diseases (6) · Digestive System Diseases (6)
Zoledronic Acid (10) · Leuprolide (7) · Triptorelin Pamoate (5) · Goserelin (4) · bicalutamide (4) · luprolide acetate gel depot (4) · 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (3) · Dutasteride (3) · Flutamide (3) · Sodium Chloride (3) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (3) · enzalutamide (3) · Abiraterone Acetate (2) · Ciprofloxacin (2) · Finasteride (2)
Novartis Pharmaceuticals (7) · Novartis (3) · Astellas Pharma Inc (2) · Blue Earth Diagnostics (2) · Columbia University (2) · Corewell Health East (2) · Ipsen (2) · Konkuk University Medical Center (2) · Sanofi (2) · Yonsei University (2) · Advanced Medical Diagnostics s.a. (1) · Albany Medical College (1) · American Medical Systems (1) · Astellas Pharma Singapore Pte. Ltd. (1) · AstraZeneca (1)
United States (35) · Canada (8) · France (6) · Netherlands (6) · Denmark (5) · Germany (5) · Italy (5) · South Korea (5) · Spain (5) · United Kingdom (5) · Belgium (4) · Brazil (4) · Finland (4) · Turkey (Türkiye) (4) · China (3)
Matthew Babcock, PhD (2) · Anne Sophie P. Kancir, MD PhD (1) · Badar Mian, MD (1) · Bertrand Tombal, Prof (1) · Boris Mraovic, MD (1) · Brian Helfand, M.D. (1) · Brian J Moran, MD (1) · Bruce Kava, MD (1) · Buys M Yvonne, MD FRCSC (1) · Byung Ha Chung, Medicine (1)
PMID 17724727, PMID 19143027, PMID 22405509, PMID 24354113, PMID 25627076, PMID 27286961, PMID 30028657, PMID 30224019, PMID 30300367, PMID 30352714, PMID 30939628, PMID 31329922, PMID 31643128, PMID 31797684, PMID 32444264, PMID 34068083, PMID 35280654, PMID 35422136, PMID 35971857, PMID 36419331, PMID 37101774, PMID 38656229, PMID 40389061, PMID 41729277, PMID 4723349
2023 (2), 2025 (1), K01HL164978 (1), R01CA138627 (1)